Aditxt, Inc. Cash and Cash Equivalents
Aditxt, Inc. (ADTX) had Cash and Cash Equivalents of $163.04 thousand as of 2025-09-30, per its 10-Q filed 2025-11-18.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-11-18
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $163.04K.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $323.68K.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $476.42K.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $833.03K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $163.04K 10-Q · filed 2025-11-18 |
| 2025-06-30 | $323.68K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $476.42K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $833.03K 10-Q · filed 2025-05-15 |
| 2024-09-30 | $328.60K 10-Q · filed 2024-11-18 |
| 2024-06-30 | $91.22K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $88.67K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $97.10K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.65M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $95.95K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $302.51K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.77M 10-K · filed 2024-04-16 |
| 2022-09-30 | $9.24M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $803.97K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.12M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.87M 10-K · filed 2023-04-17 |
| 2021-09-30 | $5.47M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $8.61M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $14.05M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $10.50M 10-K · filed 2022-03-31 |
| 2020-09-30 | $13.72M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $49.92K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $46.58K 10-Q · filed 2021-05-12 |
| 2019-12-31 | $4.09K 10-Q · filed 2021-11-15 |
| 2019-09-30 | $32.98K 10-Q · filed 2020-11-13 |
| 2019-06-30 | $4.46K 10-Q · filed 2020-08-13 |
| 2018-12-31 | $115.71K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |